George Mason University
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, George Mason University sits in the top decile of US sponsors by registered trial count (#626 of 15,742 sponsors by registered trial count).
George Mason University: 25 sponsored US clinical trials, 4 recruiting.
George Mason University sponsors 25 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 18 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Use of Standardized Assessment Tools, with 1 trials.
Top-decile sponsor footprint
George Mason University ranks in the top decile of sponsors by registered trial count (#626 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
18 of 18 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
25 total, page 1 of 1
Brief Inhibitory Training for Eating - Intervention
NCT07592728
PARCA (a Digital Tool) to Improve Justice and Health
NCT07199374
PrEP Intervention in Prince George's County, Maryland
NCT06141408
Effects of Gait Retraining on Lower Extremity Biomechanics
NCT03663790
Parenting Mindfully Study II
NCT05370768
Evaluating Conversational Artificial Intelligence for Depression Management
NCT07105397
An Aging Healthy Intervention for Older Adults Delivered by Community Health Workers in Senior Centers: A Clinical Trial
NCT07428174
WECARE: A Behavioral Intervention for Dementia Caregivers
NCT05992467
Group Digital Gaming: Experiences of Older Adults Living With Dementia in an Activity for Cognitive Impairment
NCT07541144
Imaging Biomarkers for Myofascial Pain
NCT06060925
Individualized Nutrition Therapy for Preventing or Delaying Onset of Type-2 Diabetes
NCT05161897
RHBS Brain and Balance Study of Older Adults
NCT04796870
Effects of Arts Engagement on Physical Performance, Cognition, Social Isolation, and Self-Perception in Older Adults
NCT04281654
Effect of Multimodal Exercise Training on Walking Economy in Individuals With Parkinson's Disease
NCT03864393
Recovery, Fatigability, and Proteomic Response to Aerobic Exercise Training in Healthy Individuals
NCT03800342
Mechanisms of Arm Recovery in Stroke Patients With Hand Paralysis
NCT03067818
Prebiotic Effects of Isomalto-oligosaccharide
NCT02433873
Examining the Effects of (MiM) Treatment on Emotional and Cognitive Functioning of Residents in Long-term Care
NCT02219620
Parenting Mindfully Study
NCT02038231
Parent-Adolescent Interactions and Adolescent Development
NCT01572441
Mild Cognitive Impairment and Obstructive Sleep Apnea
NCT01482351
Effects of Reiki, Yoga, Meditation, on the Physical and Psychological Symptoms of Chemotherapy-Induced Peripheral Neuropathy
NCT01569269
Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment
NCT02228044
Implementing & Testing Assessment and Referral Technologies in Juvenile Justice
NCT01372046
Effects of Manualized Treatment in a Seamless System
NCT01372033
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Where George Mason University enrollment is open (later-stage tilt)
4 recruiting of 25 indexed (16% open); 18 completed (72%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Use of Standardized Assessment Tools (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
George Mason University: open-pipeline peers nationwide
Peers matched on 25 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
George Mason University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 25 trials (± recruiting share)
- Arcus Biosciences · 25 trials · 12% recruiting
- Arcutis Biotherapeutics · 25 trials · 8% recruiting
- Ardelyx · 25 trials · 12% recruiting
- Drexel University College of Medicine · 25 trials · 0% recruiting
Sponsors near 16% open enrollment (± trial volume)
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
- University of Arizona · 16% recruiting · 349 trials
- University of California, San Francisco · 16% recruiting · 1,713 trials
- University of Oregon · 16% recruiting · 63 trials
Related
What to do with this George Mason University page
25 registered trials is a research-attention snapshot, not an endorsement of George Mason University or any single study.
- 4 of George Mason University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Use of Standardized Assessment Tools is the condition George Mason University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Use of Standardized Assessment Tools trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
George Mason University pipeline card: 25 registered trials from official public datasets.Report a data error.